ARTICLE | Clinical News
IPH4102: Preliminary Ph I data
November 4, 2016 5:33 PM UTC
Preliminary data from 16 evaluable patients with KIR3dL2-positive, relapsed or refractory CTCL in the dose-escalation portion of the open-label, international Phase I IPH4102-101 trial showed that 0.0...
BCIQ Company Profiles